Cochrane Abstracts
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risedronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/Risedronate_for_the_primary_and_secondary_prevention_of_osteoporotic_fractures_in_postmenopausal_women. Accessed 28 September 2023.
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/Risedronate_for_the_primary_and_secondary_prevention_of_osteoporotic_fractures_in_postmenopausal_women. Accessed September 28, 2023.
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/Risedronate_for_the_primary_and_secondary_prevention_of_osteoporotic_fractures_in_postmenopausal_women
Risedronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women [Internet]. In: Cochrane Abstracts. [cited 2023 September 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/Risedronate_for_the_primary_and_secondary_prevention_of_osteoporotic_fractures_in_postmenopausal_women.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
ID - 436140
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436140/all/Risedronate_for_the_primary_and_secondary_prevention_of_osteoporotic_fractures_in_postmenopausal_women
DB - Evidence Central
DP - Unbound Medicine
ER -
